ZA741917B - 1-(imidazole-1-yl)-isoquinolines and process for preparing them - Google Patents

1-(imidazole-1-yl)-isoquinolines and process for preparing them

Info

Publication number
ZA741917B
ZA741917B ZA00741917A ZA741917A ZA741917B ZA 741917 B ZA741917 B ZA 741917B ZA 00741917 A ZA00741917 A ZA 00741917A ZA 741917 A ZA741917 A ZA 741917A ZA 741917 B ZA741917 B ZA 741917B
Authority
ZA
South Africa
Prior art keywords
isoquinolines
imidazole
preparing
Prior art date
Application number
ZA00741917A
Other languages
English (en)
Inventor
U Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA741917B publication Critical patent/ZA741917B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ZA00741917A 1973-03-26 1974-03-25 1-(imidazole-1-yl)-isoquinolines and process for preparing them ZA741917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732314985 DE2314985A1 (de) 1973-03-26 1973-03-26 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ZA741917B true ZA741917B (en) 1975-03-26

Family

ID=5875934

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00741917A ZA741917B (en) 1973-03-26 1974-03-25 1-(imidazole-1-yl)-isoquinolines and process for preparing them

Country Status (13)

Country Link
US (1) US3914236A (de)
JP (1) JPS49126684A (de)
AT (1) AT337183B (de)
BE (1) BE812841A (de)
DD (1) DD114607A5 (de)
DE (1) DE2314985A1 (de)
ES (1) ES424436A1 (de)
FR (1) FR2223024B1 (de)
GB (1) GB1464289A (de)
HU (1) HU168524B (de)
IL (1) IL44478A (de)
NL (1) NL7403829A (de)
ZA (1) ZA741917B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54151990A (en) * 1978-04-17 1979-11-29 Beiersdorf Ag Novel condensated nitrogenncontained heterocyclic compound and its manufacture
US5716972A (en) * 1993-01-13 1998-02-10 Smithkline Beecham Corporation Pyridyl substituted imidazoles
DE4215587A1 (de) * 1992-05-12 1993-11-18 Bayer Ag Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
US5446071A (en) * 1994-11-18 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
WO1999018077A1 (en) 1997-10-02 1999-04-15 Eisai Co., Ltd. Fused pyridine derivatives
EP1613604B1 (de) * 2003-04-16 2006-07-05 Huntsman Advanced Materials (Switzerland) GmbH 1-imidazolylmethyl-substituirte-2-naphtol unh ihre verwendung als niedertemperatur-härtungsbeschleuniger

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485733A (de) * 1967-04-26 1970-02-15 Agripat Sa Verfahren zur Herstellung halogensubstituierter Imidazol-Derivate
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
DE1964996C3 (de) * 1969-12-24 1978-11-30 Bayer Ag, 5090 Leverkusen 9-Azolyl-fluoren-9-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Regulierung des Pflanzenwachstums
FR2076625A5 (de) * 1970-01-21 1971-10-15 Rhone Poulenc Sa

Also Published As

Publication number Publication date
AT337183B (de) 1977-06-10
ES424436A1 (es) 1977-05-16
HU168524B (de) 1976-05-28
FR2223024B1 (de) 1978-01-06
FR2223024A1 (de) 1974-10-25
BE812841A (fr) 1974-09-26
DE2314985A1 (de) 1974-10-17
AU6709874A (en) 1975-09-25
GB1464289A (en) 1977-02-09
NL7403829A (de) 1974-09-30
JPS49126684A (de) 1974-12-04
US3914236A (en) 1975-10-21
ATA245274A (de) 1976-10-15
DD114607A5 (de) 1975-08-12
IL44478A (en) 1977-07-31
IL44478A0 (en) 1974-06-30

Similar Documents

Publication Publication Date Title
HU173783B (hu) Sposob poluchenija monopeptidaminov
YU52679A (en) Process for preparing new imidazole derivatives
HU174374B (hu) Sposob poluchenija 7-trans-9-cis-dodekadien-1-il-acetata
HU170936B (hu) Sposob poluchenija proizvodnykh pirazola
YU104874A (en) Process for preparing 1-substituted pyrazolones-(5)
YU36374A (en) Process for preparing azines
CS183763B2 (en) Process for preparing d-homosteroides
CS189623B2 (en) Process for preparing 4-imidothiazetidin-2-one
CA1021802A (en) 22-dehydro-25-hydroxycholecalciferol and process for preparing same
CS189676B2 (en) Process for preparing poly-n-alkyliminoalanes
IL44478A0 (en) 1-(imidazol-1/yl)-isoquinolines and process for preparing them
GB1404442A (en) Process for preparing 3-anilino-pyrazolones-5
IL45804A0 (en) Process for preparing n-trimetylsilylacetamide
YU280681A (en) Process for preparing 1-substituted pyrazlones-(5)
ZA744154B (en) Novel imidazole derivatives and process for their preparation
IL45977A0 (en) Process for preparing cis-olefins
GB1403875A (en) Process for preparing sulphoxides
AU480126B2 (en) l-(IMDAZOLE-l-YL)-ISO-QUINOLINES AND PROCESS FOR PREPARING THEM
CS183759B2 (en) Process for preparing acylaminophenylacetamidines
YU298380A (en) Process for preparing new nitroimidazoles
YU280781A (en) Process for preparing 1-substituted pyrazolones-(5)
CA986511A (en) Process for preparing 1-(2-arylsulfonylaminoethyl)-2-methyl-5-nitroimidazoles
CS181761B2 (en) Process for preparing bisphenylolmethane or bisphenylolpropane
IL45334A0 (en) N-substituted cycloserines and process for preparing them
CS187415B2 (en) Process for preparing penicilines